SP

Shahabas Para Chalil

Active Director Director DIN 10992349
DIN 10992349 First appointment Mar 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shahabas Para Chalil

Data last updated:

Shahabas Para Chalil is a Director at Fineline Surgicals And Biomedicals Private Limited (since 2025). The company operates in Healthcare.

DIN 10992349
Primary Designation Director
Industry Healthcare
First Appointment 08 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Mar 20252025Active

Board colleagues of Shahabas Para Chalil

NameDINCompanyDesignation
Akash Manoj P K10992348Fineline Surgicals And Biomedicals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Fineline Surgicals And Biomedicals Private Limited
Premium access

Shareholding and investment profile for Shahabas Para Chalil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shahabas Para Chalil

Shahabas Para Chalil currently holds 1 directorship: Fineline Surgicals And Biomedicals Private Limited (Director, since 08 Mar 2025).

Shahabas Para Chalil was first appointed on 08 Mar 2025 as Director at Fineline Surgicals And Biomedicals Private Limited.

The current boards of Shahabas Para Chalil's companies include Akash Manoj P K (Fineline Surgicals And Biomedicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available